Neuroendocrine Tumors

From the reviews: "This text is a welcome addition to the Current Clinical Oncology series ... . The book is extremely broad in its coverage and does include just about all of the neuroendocrine tumours ... . as a handy lightweight reference it is an extremely useful addition both to the hospital library and the personal library of clinicians who manage these tumours. ... it is a very readable reference book and a great asset to the library ... ." (Nick Reed, Oncology News, Vol. 6 (6), January/February, 2012) "Individual chapters are discussing the epidemiology and pathology of neuroendocrine tumors as well as problems of multiple endocrine neoplasia (MEN syndrome). Special attention is paid to other genetic syndromes such as von Hippel Lindau syndrome, neurofibromatosis, tuberous sclerosis and paraganglioma-phaechromocytoma. ... the editors and authors hope that their work will help to demystify some important misconceptions regarding neuroendocrione tumors and that it maz help to improve the treatment of patients and families affected by this disease." (Endocrine Regulations, January, 2012) "The book is intended for both medical and surgical specialists with an interest in neuroendocrine tumors. The depth and presentation of the material is excellent for surgical/medical trainees as well as practicing surgeons/internists. ... This book addresses the entire spectrum of neuroendocrine tumor management from epidemiology to diagnosis, staging, and treatment. ... The way this book discusses the entire breadth of neuroendocrine tumors in an easily readable yet remarkably informative manner is refreshing." (Timothy Platz, Doody's Book Reviews, November, 2011)

• Global Epidemiology of Neuroendocrine Tumors.- Pathology.- Multiple Endocrine Neoplasia.- Other Genetic Syndromes.- Imaging of Neuroendocrine Tumors.- Surgical Management of Sporadic Gastrointestinal Neuroendocrine Tumors.- Management of Neuroendocrine Tumor Hormonal Syndromes.- Management of Metastic Carcinoid Tumors.- Medical Management of Islet Cell Carcinoma.- Poorly Differentiated Neuroendocrine Tumors.- Hereditary and Sporadic Medullary Thyroid Carcinoma.- Adrenocortical Carcinoma.- Pheochromocytoma.- Merkel cell carcinomas.